Soleus Capital
Venture capitalGreenwich · Late Stage
Also known as SOLEUS CAPITAL MANAGEMENT, L.P.
Investment thesis
Soleus Capital invests across the healthcare and life sciences sector, targeting innovative areas such as biotech, medtech, diagnostics, and genomics. The firm invests across the full healthcare lifecycle, backing companies ranging from developmental-stage ventures through to commercial-stage businesses.
Source: firm website, verified Aug 25, 2026.
What they invest in
from 8 of 8 portfolio companiesBiotech ×6Healthtech ×4AI & Machine Learning ×3Medical Devices ×2Data & Infrastructure ×1Deep Tech ×1Digital Health ×1Marketing Tech ×1
HQs:United States×6
Investments · 8 tracked
founders shown can be your intro pathBy year:2026 · 22025 · 22021 · 15 dated
Helicons develops a peptide-based therapeutic platform designed to target intracellular proteins previously considered undruggable by combining the specificity of antibodies with the cell-penetrating properties of small molecules.
AI & Machine LearningBiotechDeep TechMedical Devices
Mathai Mammen(CEO, President and Chairman)
Co-investorsARCH Venture PartnersCatalio Capital Management, LPForesite CapitalFrazier Life SciencesGeneral CatalystNextech Invest+5 more
Variantyx is a molecular diagnostics company offering genetic testing for rare genetic disorders, reproductive genetics, and precision oncology.
AI & Machine LearningBiotechDigital HealthHealthtechFramingham, US
Haim Neerman(Co-founder)inTomer Jackman(Co-founder & VP Customer Support and Lab Services)inJeffrey Weisberg(Chief Financial Officer)inYaron Rachmany(Operations, R&D, IT (executive))inChristine Stanley(Chief Genomics and Compliance Officer)inEyal Reinstein(Chief Medical Officer)in
Co-investors20/20 HealthCare Partners LLCBosch VenturesNew Era Capital PartnersOrbiMedPeregrine VenturesPitango+2 more
Abcuro develops therapies that target highly cytotoxic T cells for autoimmune diseases, including its lead candidate ulviprubart for inclusion body myositis.
BiotechHealthtechNewton, US
Steven A. Greenberg(Chief Scientific Advisor & Co-Founder)Steven A. Greenberg, MD(Chief Scientific Advisor & Co-Founder)John Alexander Martin(Executive Officer, Director)Stefano Gulla(Executive Officer)Evan Thompson(Executive Officer)David de Graaf(Executive Officer, Director)
Co-investorsBain Capital Life SciencesNew Enterprise Associates (NEA)RA CapitalSamsara BioCapitalSanofi VenturesMass General Brigham Ventures+8 more
BiotechHunt Valley, US
Chad Gordon(Manager)Greg Cole(Executive Officer, Director)Jesse Christopher(Executive Officer, Director)
BoardJohn Parker(Director)Jill Kalmann(Director)Matthew B. Swartz(Manager)
Co-investorsTEDCO
Neurona is a clinical-stage biotherapeutics company developing allogeneic, off-the-shelf regenerative neural cell therapies that integrate into neural circuits to treat chronic neurological disorders.
BiotechHealthtechSouth San Francisco, US
Cory Nicholas(Executive Officer, Director, Promoter)James Stutz(Executive Officer)Arnold Kriegstein(Director)
BoardPeter Svennilson(Director)inTim Kutzkey(Director)Ray Kelleher(Director)
Co-investorsBerkeley FrontierIaso VenturesThe Column GroupYsios CapitalAlexandriaFidelity Investments+7 more
Parse.ly is a content analytics and audience intelligence platform offering a real-time dashboard, a content recommendation API, a data pipeline to warehouses, and AI-driven insights.
Data & InfrastructureMarketing TechMedia & Entertainment
Co-investorsHaatchHorizon Technology FinanceJanus Henderson InvestorsSahsen VenturesSARAS CAPITAL
HealthtechIrvine, US
Kenny Chang(Executive Officer)W. Ronald Redmond(Director)Vijay Dhaka(Executive Officer)Philong Pham(Executive Officer, Director)Hongsheng Tong(Executive Officer, Director)
Co-investorsBlackRockEndeavour VisionMVM Life Science PartnersRTW Investments L.P.venBio Global StrategicVivo Capital
Tectonic is a clinical-stage biotechnology company developing therapeutic proteins and antibodies that target G-Protein Coupled Receptors (GPCRs) using a proprietary platform called GEODe™.
AI & Machine LearningBiotechMedical DevicesWatertown, US
Timothy A. Springer(Co-Founder)Andrew C. KruseTimothy Springer(Director)Andrew Kruse(Director)Alise Reicin(Executive Officer, Director)Daniel Lochner(Executive Officer)
Co-investorsEcoR1 CapitalVida VenturesAlly Bridge GroupClarusPolaris Partners
Exits · 1
IPOs and acquisitions across the tracked portfolioParabilis MedicinesNASDAQ: PBLS
Portfolio news
latest coverage across their companies
Abcuro · clinicaltrialsarena.com · Aug 19, 2026
Parabilis Medicines · pharmexec.com · Jun 19, 2026
Longeviti Neuro Solutions · technical.ly · Sep 11, 2025
Frequently asked questions
- What stage does Soleus Capital invest at?
- Soleus Capital invests at the Late Stage stage.
- What sectors does Soleus Capital focus on?
- Soleus Capital focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Soleus Capital located?
- Soleus Capital is headquartered in Greenwich, US.
Images
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.